← FDA Drug Approvals (Drugs@FDA)

BORTEZOMIB

NDA · New Drug Application · Sponsor: SHILPA · Approved 2024-08-26

Drug application

FDA Application #

NDA212782

Application type

New Drug Application

Brand name

BORTEZOMIB

Generic name

BORTEZOMIB

Active ingredients

BORTEZOMIB

Dosage form

SOLUTION

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

SHILPA

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2024-08-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown